scholarly journals Metaproteomics—An Advantageous Option in Studies of Host–Microbiota Interaction

2021 ◽  
Vol 9 (5) ◽  
pp. 980
Author(s):  
Oleg Karaduta ◽  
Zeljko Dvanajscak ◽  
Boris Zybailov
Keyword(s):  
Immune System ◽  
Gut Microbiota ◽  
Therapeutic Target ◽  
Intestinal Microbiome ◽  
Current Status ◽  
Digestive Efficiency ◽  
Fecal Microbiome ◽  
Omics Technologies ◽  
Diet Modification ◽  
Host Health

Gut microbiome contributes to host health by maintaining homeostasis, increasing digestive efficiency, and facilitating the development of the immune system. Manipulating gut microbiota is being recognized as a therapeutic target to manage various chronic diseases. The therapeutic manipulation of the intestinal microbiome is achieved through diet modification, the administration of prebiotics, probiotics, or antibiotics, and more recently, fecal microbiome transplantation (FMT). In this opinion paper, we give a perspective on the current status of application of multi-omics technologies in the analysis of host–microbiota interactions. The aim of this paper was to highlight the strengths of metaproteomics, which integrates with and often relies on other approaches.

scholarly journals Intestinal Microbiota as Modulators of the Immune System and Neuroimmune System: Impact on the Host Health and Homeostasis

2015 ◽  
Vol 2015 ◽  
pp. 1-14 ◽  
Author(s):  
Carlos Magno da Costa Maranduba ◽  
Sandra Bertelli Ribeiro De Castro ◽  
Gustavo Torres de Souza ◽  
Cristiano Rossato ◽  
Francisco Carlos da Guia ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Ulcerative Colitis ◽  
Immune System ◽  
Gut Microbiota ◽  
Intestinal Microbiota ◽  
Present Review ◽  
Present Moment ◽  
Depression And Anxiety ◽  
Neuroimmune System ◽  
Host Health

Many immune-based intestinal disorders, such as ulcerative colitis and Crohn’s disease, as well as other illnesses, may have the intestines as an initial cause or aggravator in the development of diseases, even apparently not correlating directly to the intestine. Diabetes, obesity, multiple sclerosis, depression, and anxiety are examples of other illnesses discussed in the literature. In parallel, importance of the gut microbiota in intestinal homeostasis and immunologic conflict between tolerance towards commensal microorganisms and combat of pathogens is well known. Recent researches show that the immune system, when altered by the gut microbiota, influences the state in which these diseases are presented in the patient directly and indirectly. At the present moment, a considerable number of investigations about this subject have been performed and published. However, due to difficulties on correlating information, several speculations and hypotheses are generated. Thus, the present review aims at bringing together how these interactions work—gut microbiota, immune system, and their influence in the neuroimmune system.

scholarly journals Comprehensive Bibliometric Analysis of the Kynurenine Pathway in Mood Disorders: Focus on Gut Microbiota Research

2021 ◽  
Vol 12 ◽  
Author(s):  
Xiuqing Zhu ◽  
Jinqing Hu ◽  
Shuhua Deng ◽  
Yaqian Tan ◽  
Chang Qiu ◽  
...  
Keyword(s):  
Immune System ◽  
Gut Microbiota ◽  
Citation Analysis ◽  
Mood Disorders ◽  
Bibliometric Analysis ◽  
The United States ◽  
Kynurenine Pathway ◽  
Current Status ◽  
Future Research ◽  
Low Grade

Background: Emerging evidence implicates the dysregulated kynurenine pathway (KP), an immune-inflammatory pathway, in the pathophysiology of mood disorders (MD), including depression and bipolar disorder characterized by a low-grade chronic pro-inflammatory state. The metabolites of the KP, an important part of the microbiota-gut-brain axis, serve as immune system modulators linking the gut microbiota (GM) with the host central nervous system.Aim: This bibliometric analysis aimed to provide a first glimpse into the KP in MD, with a focus on GM research in this field, to guide future research and promote the development of this field.Methods: Publications relating to the KP in MD between the years 2000 and 2020 were retrieved from the Scopus and Web of Science Core Collection (WoSCC), and analyzed in CiteSpace (5.7 R5W), biblioshiny (using R-Studio), and VOSviewer (1.6.16).Results: In total, 1,064 and 948 documents were extracted from the Scopus and WoSCC databases, respectively. The publications have shown rapid growth since 2006, partly owing to the largest research hotspot appearing since then, “quinolinic acid.” All the top five most relevant journals were in the neuropsychiatry field, such as Brain Behavior and Immunity. The United States and Innsbruck Medical University were the most influential country and institute, respectively. Journal co-citation analysis showed a strong tendency toward co-citation of research in the psychiatry field. Reference co-citation analysis revealed that the top four most important research focuses were “kynurenine pathway,” “psychoneuroimmunology,” “indoleamine 2,3-dioxygenase,” and “proinflammatory cytokines,” and the most recent focus was “gut-brain axis,” thus indicating the role of the KP in bridging the GM and the host immune system, and together reflecting the field’s research foundations. Overlap analysis between the thematic map of keywords and the keyword burst analysis revealed that the topics “Alzheimer’s disease,” “prefrontal cortex,” and “acid,” were research frontiers.Conclusion: This comprehensive bibliometric study provides an updated perspective on research associated with the KP in MD, with a focus on the current status of GM research in this field. This perspective may benefit researchers in choosing suitable journals and collaborators, and aid in the further understanding of the field’s hotspots and frontiers, thus facilitating future research.

scholarly journals Intestinal Microbiota in Common Chronic Inflammatory Disorders Affecting Children

2021 ◽  
Vol 12 ◽  
Author(s):  
Anna Torun ◽  
Anna Hupalowska ◽  
Piotr Trzonkowski ◽  
Jaroslaw Kierkus ◽  
Beata Pyrzynska
Keyword(s):  
Quality Of Life ◽  
Immune System ◽  
Gut Microbiota ◽  
Autoimmune Diseases ◽  
Pediatric Population ◽  
Genetically Engineered ◽  
Intestinal Microbiome ◽  
Antigen Receptors ◽  
Inflammatory Disorders

The incidence and prevalence rate of chronic inflammatory disorders is on the rise in the pediatric population. Recent research indicates the crucial role of interactions between the altered intestinal microbiome and the immune system in the pathogenesis of several chronic inflammatory disorders in children, such as inflammatory bowel disease (IBD) and autoimmune diseases, such as type 1 diabetes mellitus (T1DM) and celiac disease (CeD). Here, we review recent knowledge concerning the pathogenic mechanisms underlying these disorders, and summarize the facts suggesting that the initiation and progression of IBD, T1DM, and CeD can be partially attributed to disturbances in the patterns of composition and abundance of the gut microbiota. The standard available therapies for chronic inflammatory disorders in children largely aim to treat symptoms. Although constant efforts are being made to maximize the quality of life for children in the long-term, sustained improvements are still difficult to achieve. Additional challenges are the changing physiology associated with growth and development of children, a population that is particularly susceptible to medication-related adverse effects. In this review, we explore new promising therapeutic approaches aimed at modulation of either gut microbiota or the activity of the immune system to induce a long-lasting remission of chronic inflammatory disorders. Recent preclinical studies and clinical trials have evaluated new approaches, for instance the adoptive transfer of immune cells, with genetically engineered regulatory T cells expressing antigen-specific chimeric antigen receptors. These approaches have revolutionized cancer treatments and have the potential for the protection of high-risk children from developing autoimmune diseases and effective management of inflammatory disorders. The review also focuses on the findings of studies that indicate that the responses to a variety of immunotherapies can be enhanced by strategic manipulation of gut microbiota, thus emphasizing on the importance of proper interaction between the gut microbiota and immune system for sustained health benefits and improvement of the quality of life of pediatric patients.

Immunological Responses to Gut Bacteria

2012 ◽  
Vol 95 (1) ◽  
pp. 35-49 ◽  
Author(s):  
Julia M Green-Johnson
Keyword(s):  
Immune System ◽  
Gut Microbiota ◽  
Immune Responses ◽  
Innate Immune ◽  
Innate Immune Responses ◽  
Host Defenses ◽  
Immunological Responses ◽  
Host Health ◽  
Microbe Interactions ◽  
Host Microbe Interactions

Abstract The integral nature of interactions between the gut microbiota and host is especially evident with respect to effects on the immune system and host defenses. Host-microbiota interactions are increasingly being revealed as complex and dynamic, with far-reaching effects on varied aspects of host health. This review focuses on adaptive and innate immune responses to the gut microbiota and the bidirectional nature of these host-microbe interactions.

scholarly journals Immune System Modulations by Products of the Gut Microbiota

Vaccines ◽  
2020 ◽  
Vol 8 (3) ◽  
pp. 461
Author(s):  
Thierry Chénard ◽  
Karine Prévost ◽  
Jean Dubé ◽  
Eric Massé
Keyword(s):  
Immune System ◽  
Bacterial Community ◽  
Gut Microbiota ◽  
Small Molecules ◽  
Immune Cells ◽  
Therapeutic Target ◽  
Symbiotic Relationship ◽  
Prevention And Treatment ◽  
By Products

The gut microbiota, which consists of all bacteria, viruses, fungus, and protozoa living in the intestine, and the immune system have co-evolved in a symbiotic relationship since the origin of the immune system. The bacterial community forming the microbiota plays an important role in the regulation of multiple aspects of the immune system. This regulation depends, among other things, on the production of a variety of metabolites by the microbiota. These metabolites range from small molecules to large macro-molecules. All types of immune cells from the host interact with these metabolites resulting in the activation of different pathways, which result in either positive or negative responses. The understanding of these pathways and their modulations will help establish the microbiota as a therapeutic target in the prevention and treatment of a variety of immune-related diseases.

scholarly journals Reconstruction and dynamics of human intestinal microbiome observed in situ

2020 ◽  
Author(s):  
Xiaolin Liu ◽  
Min Dai ◽  
Yue Ma ◽  
Na Zhao ◽  
Huijie Zhang ◽  
...  
Keyword(s):  
Gut Microbiome ◽  
Bacterial Species ◽  
Intestinal Microbiome ◽  
Gi Tract ◽  
Fatty Acid Production ◽  
Fecal Microbiome ◽  
Host Health ◽  
Functional Capacities ◽  
Active Genes

AbstractGut microbiome are studied primarily using fecal samples in humans and we gained vital knowledge of compositional and functional capacities of gastro-intestinal microbial communities. Yet, fecal materials limit our ability to investigate microbial dynamics in different locations along GI-tract (in situ), nor in finer temporal scales as they are infrequent. With a technology developed originally for fecal material transplantation, colonic transendoscopic enteral tubing, we were able to sample ileocecal microbiome twice daily, and carried out metagenomic as well as metatranscriptomic analyses. Ileocecal and fecal microbiome are similar in metagenomic profiling, yet their active genes (in metatranscriptomes) are highly distinct. Both were perturbed after laxatives and then became more similar to microbiome prior to treatment, demonstrating resilience as an innate property of gut microbiome. Ileocecal microbiome transcriptomes sampled during day and night revealed diurnal rhythmes exist in certain bacterial species and functional pathways, in particular those related to short-chain fatty acid production. Lastly, metabolomic analysis in fecal and urine samples mirrored the perturbance and recovery in gut microbiome, indicating crucial contribution of gut microbiome to many of the key metabolites involved in host health. Our study provides interesting novel insights into human gut microbiome, and demonstrates the inner resilience, diurnal rhythmes and potential consequences to the host.

scholarly journals Apis cerana gut microbiota contribute to host health though stimulating host immune system and strengthening host resistance to Nosema ceranae

2020 ◽  
Vol 7 (5) ◽  
pp. 192100 ◽  
Author(s):  
Yuqi Wu ◽  
Yufei Zheng ◽  
Yanan Chen ◽  
Gongwen Chen ◽  
Huoqing Zheng ◽  
...  
Keyword(s):  
Immune System ◽  
Gut Microbiota ◽  
Host Resistance ◽  
Apis Cerana ◽  
Gut Bacteria ◽  
Nosema Ceranae ◽  
Host Immune System ◽  
Jnk Pathway ◽  
Host Health

Gut microbial communities play vital roles in the modulation of many insects' immunity, including Apis mellifera . However, little is known about the interaction of Apis cerana gut bacteria and A. cerana immune system. Here in this study, we conducted a comparison between germ-free gut microbiota deficient (GD) workers and conventional gut community (CV) workers, to reveal the possible impact of gut microbiota on the expression of A. cerana antimicrobial peptides and immune regulate pathways. We also test whether A. cerana gut microbiota can strengthen host resistance to Nosema ceranae . We find that the expression of apidaecin , abaecin and hymenoptaecin were significantly upregulated with the presence of gut bacteria, and JNK pathway was activated; in the meanwhile, the existence of gut bacteria inhibited the proliferation of Nosema ceranae . These demonstrated the essential role of A. cerana gut microbiota to host health and provided critical insight into the honeybee host–microbiome interaction.

scholarly journals Modulation of Gut Microbiota and Immune System by Probiotics, Pre-biotics, and Post-biotics

2022 ◽  
Vol 8 ◽  
Author(s):  
Yue Liu ◽  
Jiaqi Wang ◽  
Changxin Wu
Keyword(s):  
Immune Response ◽  
Immune System ◽  
Gut Microbiota ◽  
Bioactive Metabolites ◽  
Beneficial Effects ◽  
Complex Microbial Community ◽  
Host Health ◽  
Underlying Mechanisms ◽  
The Impact ◽  
Wall Components

The human gastrointestinal tract harbours a complex microbial community, which interacts with the mucosal immune system closely. Gut microbiota plays a significant role in maintaining host health, which could supply various nutrients, regulate energy balance, modulate the immune response, and defence against pathogens. Therefore, maintaining a favourable equilibrium of gut microbiota through modulating bacteria composition, diversity, and their activity is beneficial to host health. Several studies have shown that probiotics and pre-biotics could directly and indirectly regulate microbiota and immune response. In addition, post-biotics, such as the bioactive metabolites, produced by gut microbiota, and/or cell-wall components released by probiotics, also have been shown to inhibit pathogen growth, maintain microbiota balance, and regulate an immune response. This review summarises the studies concerning the impact of probiotics, pre-biotics, and post-biotics on gut microbiota and immune systems and also describes the underlying mechanisms of beneficial effects of these substances. Finally, the future and challenges of probiotics, pre-biotics, and post-biotics are proposed.

scholarly journals Immune system stimulation by the native gut microbiota of honey bees

2017 ◽  
Vol 4 (2) ◽  
pp. 170003 ◽  
Author(s):  
Waldan K. Kwong ◽  
Amanda L. Mancenido ◽  
Nancy A. Moran
Keyword(s):  
Immune System ◽  
Gut Microbiota ◽  
Honey Bee ◽  
E Coli ◽  
Crucial Component ◽  
Host Health ◽  
Gut Symbionts ◽  
Microbial Symbionts ◽  
Insect Innate Immunity

Gut microbial communities can greatly affect host health by modulating the host's immune system. For many important insects, however, the relationship between the gut microbiota and immune function remains poorly understood. Here, we test whether the gut microbial symbionts of the honey bee can induce expression of antimicrobial peptides (AMPs), a crucial component of insect innate immunity. We find that bees up-regulate gene expression of the AMPs apidaecin and hymenoptaecin in gut tissue when the microbiota is present. Using targeted proteomics, we detected apidaecin in both the gut lumen and the haemolymph; higher apidaecin concentrations were found in bees harbouring the normal gut microbiota than in bees lacking gut microbiota. In in vitro assays, cultured strains of the microbiota showed variable susceptibility to honey bee AMPs, although many seem to possess elevated resistance compared to Escherichia coli . In some trials, colonization by normal gut symbionts resulted in improved survivorship following injection with E. coli . Our results show that the native, non-pathogenic gut flora induces immune responses in the bee host. Such responses might be a host mechanism to regulate the microbiota, and could potentially benefit host health by priming the immune system against future pathogenic infections.

Sign in / Sign up

Export Citation Format

Share Document